BioSpace News Archive

AlzeCure Pharma AB a pharmaceutical company that develops a broad portfolio of drug candidates for diseases affecting the central nervous system, with projects in both Alzheimer’s disease and pain, announced that the company arranges a Capital Markets Day on May 17 at 10:00-11:30 CET with Professor Bengt Winblad as an invited guest speaker.

Weslie Janeway joins bit.bio board.

Fennec Pharmaceuticals Inc., a specialty pharmaceutical company, reported its financial results for the fiscal quarter ended March 31, 2023 and provided a business update.

Haemonetics Corporation announced that financial results for its fourth quarter fiscal 2023, which ended April 1, 2023, are available on its Investor Relations website.

TCR2 Therapeutics Inc., a clinical-stage cell therapy company with a pipeline of novel next-generation T cell therapies for patients suffering from solid tumors, announced financial results for the first quarter ended March 31, 2023 and provided a corporate update.

Revvity, Inc . (NYSE: PKI), today reported financial results for the first quarter ended April 2, 2023.

Immunic, Inc., a biotechnology company developing a clinical pipeline of orally administered, small molecule therapies for chronic inflammatory and autoimmune diseases, announced financial results for the first quarter ended March 31, 2023, and provided a corporate update.

Nuvalent, Inc. announced plans to share preliminary data from the dose-escalation portion of its ongoing ALKOVE-1 Phase 1/2 clinical trial for NVL-655, a novel ALK-selective inhibitor, in the second half of 2023, and reported first quarter 2023 financial results.

Praxis Precision Medicines, Inc. announced positive topline results from the PRAX-628 Phase 1 healthy volunteer study evaluating the safety, tolerability and pharmacokinetics of single ascending doses and multiple ascending doses of PRAX-628.

Eagle Pharmaceuticals, Inc. announced that two abstracts were accepted for presentation at the Society for Academic Emergency Medicine Annual Meeting, being held May 16-19, 2023, in Austin, Texas.